Urinary miR-21, miR-29, and miR-93: Novel biomarkers of fibrosis

American Journal of Nephrology

Volumn 36, Issue 5, 2012, Pages 412-418

  Wang, Gang ^a,b   Kwan, Bonnie Ching Ha ^a   Lai, Fernand Mac Moune ^a   Chow, Kai Ming ^a   Li, Philip Kam Tao ^a   Szeto, Cheuk Chun ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b THE FIRST AFFILIATED HOSPITAL OF SHENZHEN UNIVERSITY   (China)

Author keywords

Biomarker; Glomerulonephritis; Proteinuria

Indexed keywords

MICRORNA; MICRORNA 21; MICRORNA 29; MICRORNA 29A; MICRORNA 29B; MICRORNA 29C; MICRORNA 93; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULOSCLEROSIS; GLOMERULUS FILTRATION RATE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY FIBROSIS; MALE; PRIORITY JOURNAL; PROTEINURIA; SCAR FORMATION; SIGNAL TRANSDUCTION; URINALYSIS; URINE LEVEL;

BIOLOGICAL MARKERS; FEMALE; FIBROSIS; HUMANS; KIDNEY; KIDNEY DISEASES; MALE; MICRORNAS; MIDDLE AGED;

EID: 84867897248     PISSN: 02508095     EISSN: 14219670     Source Type: Journal    
DOI: 10.1159/000343452     Document Type: Article

References (27)

1. D'Amico G: Clinical features and natural history in adults with IgA nephropathy. Am J Kidney Dis 1988; 12:353-357.
2. Schena FP: A retrospective analysis of the natural history of primary IgA nephropathy worldwide. Am J Med 1990; 89:209-215.
3. Floege J: The pathogenesis of IgA nephropa-thy: what is new and how does it change therapeutic approaches? Am J Kidney Dis 2011; 58: 992-1004.
4. Border WA, Noble NA: TGF-beta in kidney fibrosis: a target for gene therapy. Kidney Int 1997; 51: 1388-1396.
5. Chihara Y, Ono H, Ishimitsu T, Ono Y, Ishi-kawa K, Rakugi H, Ogihara T, Matsuoka H: Roles of TGF-beta(1) and apoptosis in the progression of glomerulosclerosis in human IgA nephropathy. Clin Nephrol 2006; 65: 385-392.
6. Del Prete D, Gambaro G, Lupo A, Anglani F, Brezzi B, Magistroni R, Graziotto R, Furci L, Modena F, Bernich P, Albertazzi A, D'Angelo A, Maschio G: Precocious activation of genes of the renin-angiotensin system and the fi-brogenic cascade in IgA glomerulonephritis. Kidney Int 2003; 64:149-159.
7. Lan HY, Chung ACK: Transforming growth factor-beta and Smads. Contrib Nephrol 2011; 170: 75-82.
8. Wu W, Jiang XY, Zhang QL, Mo Y, Sun LZ, Chen SM: Expression and significance of TGF-beta 1/Smad signaling pathway in children with IgA nephropathy. World J Pediatr 2009; 5:211-215.
9. Esteller M: Non-coding R NAs in huma n disease. Nat Rev Genet 2011; 12:861-874.
10. Sayed D, Abdellatif M: MicroRNAs in development and disease. Physiol Rev 2011; 91: 827-887.
11. Lorenzen JM, Haller H, Thum T: MicroR-NAs as mediators and therapeutic targets in chronic kidney disease. Nat Rev Nephrol 2011; 7: 286-294.
12. Kantharidis P, Wang B, Carew RM, Lan HY: Diabetes complications: the microRNA perspective. Diabetes 2011; 60:1832-1837.
13. Zhong X, Chung ACK, Chen HY, Meng XM, Lan HY: Smad3-mediated upregulation of miR-21 promotes renal fibrosis. J Am Soc Nephrol 2011; 22:1668-1681.
14. Qin W, Chung ACK, Huang XR, Meng XM, Hui DSC, Yu CM, Sung JJY, Lan HY: TGF-beta/Smad3 signaling promotes renal fibro-sis by inhibiting miR-29. J Am Soc Nephrol 2011; 22:1462-1474.
15. Lan HY: Diverse roles of TGF-beta/Smads in renal fibrosis and inflammation. Int J Biol Sci 2011; 7:1056-1067.
16. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470.
17. Chandrasekaran K, Karolina DS, Seprama-niam S, Armugam A, Wintour EM, Bertram JF, Jeyaseelan K: Role of microRNAs in kidney homeostasis and disease. Kidney Int 2012; 81: 617-627.
18. Imai E, Maruyama S: microRNA-Induced IgA nephropat hy. J Am Soc Nephrol 2012; 23: 765-766.
19. Serino G, Sallustio F, Cox SN, Pesce F, Sche-na FP: Abnormal miR-148b expression promotes aberrant glycosylation of IgA1 in IgA nephropathy. J Am Soc Nephrol 2012; 23: 814-824.
20. Wang G, Kwan BCH, Lai FMM, Chow KM, Li PKT, Szeto CC: Expression of microRNAs in the urinary sediment of patients with IgA nephropathy. Dis Markers 2010; 28: 79-86.
21. Wang G, Kwan BC, Lai FM, Choi PC, Chow KM, Li PK, Szeto CC: Intrarenal expression of microR NAs in patients w it h IgA nephrop-athy. Lab Invest 2010; 90:98-103.
22. Liu Y, Taylor NE, Lu L, Usa K, Cowley AW Jr, Ferreri NR, Yeo NC, Liang M: Renal medullary microRNAs in Dahl salt-sensitive rats: miR-29b regulates several collagens and related genes. Hypertension 2010; 55:974-982.
23. Long J, Wang Y, Wang W, Chang BH, Danesh FR: Identification of microRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J Biol Chem 2010; 285: 23457-23465.
24. Kantharidis P, Wang B, Carew RM, Lan HY Diabetes complications: the microRNA perspective. Diabetes 2011; 60:1832-1837.
25. Xiong M, Jiang L, Zhou Y, Qiu W, Fang L, Tan R, Wen P, Yang J: The miR-200 family regulates TGF-β1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. Am J Physiol Renal Physiol 2012; 302:F369-F379.
26. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, Li Q, Li X, Wang W, Wang J, Jiang X, Xiang Y, Xu C, Zheng P, Zhang J, Li R, Zhang H, Shang X, Gong T, Ning G, Zen K, Zhang CY Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 2008; 18: 997-1006.
27. Kato M, Wang L, Putta S, Wang M, Yuan H, Sun G, Lanting L, Todorov I, Rossi JJ, Nata-rajan R: Post-transcriptional up-regulation of Tsc-22 by Ybx1, a target of miR-216a, mediates TGF-β-induced collagen expression in kidney cells. J Biol Chem 2010; 285: 34004-34015.